Vaxcyte, Inc.
Vaxcyte is a clinical-stage vaccine developer with minimal government dependence and no material political exposure.
BusinessWhat PCVX does
Vaxcyte develops recombinant glycoconjugate vaccines targeting bacterial infections, with a pipeline focused on pneumococcal and other vaccine candidates. The company is pre-revenue or early-stage commercial, with primary funding from venture capital and potential future revenue from vaccine sales and licensing.
12 months past · 3 months futurePCVX activity timeline
Executive Branch ConflictsPCVX held by Trump-administration officials
Lifetime Government AwardsPCVX federal contracts
PCVX doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Politicians Trading PCVXMembers of Congress with recent PCVX positions
Congressional TradesWho in Congress is trading PCVX
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills to WatchLegislation flagged by our analysis
Political ProfileWhere PCVX sits in Washington
Early-stage biotech with no lobbying activity, no campaign donations, and no legislative naming. Stock movement driven by clinical trial results and FDA decisions, not political events.
Regulatory ExposureThreats & opportunities
Regulatory threats
- FDA vaccine approval delays
- manufacturing compliance
Regulatory opportunities
- BARDA vaccine development contracts
- accelerated approval pathways
Live signals + predictions for PCVX — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades PCVX
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord